ADC Therapeutics SA (ADCT) Q2 2021 Earnings Call Transcript

·24 min read
ADC Therapeutics SA (ADCT) Q2 2021 Earnings Call Transcript

This morning, we issued a press release announcing our second-quarter 2021 financial results and business update. On today's call, Chris Martin, chief executive officer; Jennifer Herron, chief commercial officer; Jay Feingold, chief medical officer; and Jenn Creel, chief financial officer, will discuss recent business highlights and review our second-quarter 2021 financial results before opening the call for questions.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting